GUILLAIN-BARRE SYNDROME FOLLOWING ANTI-BCMA CAR-T CELL THERAPY

被引：0
|
作者：
Rutenberg, David
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.3978
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：6183A / 6184A
页数：2
相关论文
共 50 条
  • [11] Single-cell transcriptomic atlas throughout anti-BCMA CAR-T therapy in patients with multiple myeloma
    Xia, Yuan
    Zhao, Qian
    Shen, Xuxing
    Jin, Yuanyuan
    Wang, Jing
    Zhu, Jianfeng
    Chen, Lijuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [12] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    He, Shao-long
    Cheng, Yu-hang
    Wang, Di
    Xu, Meng-lei
    Que, Yi-mei
    Xu, Yan-jie
    Ma, Liang-ming
    Li, Chun-rui
    Zhou, Jian-feng
    CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 474 - 481
  • [13] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    Shao-long He
    Yu-hang Cheng
    Di Wang
    Meng-lei Xu
    Yi-mei Que
    Yan-jie Xu
    Liang-ming Ma
    Chun-rui Li
    Jian-feng Zhou
    Current Medical Science, 2021, 41 : 474 - 481
  • [14] Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma
    Samur, Mehmet K.
    Fulciniti, Mariateresa
    Aktas-Samur, Anil
    Bazarbachi, Abdul Hamid
    Tai, Yu-Tzu
    Campbell, Timothy B.
    Petrocca, Fabio
    Hege, Kristen
    Kaiser, Shari
    Anderson, Kenneth
    Munshi, Nikhil C.
    BLOOD, 2020, 136
  • [15] Memory Phenotype in Allogeneic Anti-BCMA CAR-T Cell Therapy (P-BCMA-ALLO1) Correlates with In Vivo Tumor Control
    Tseng, Hubert
    Zhang, Yan
    Cranert, Stacey A.
    Richter, Maximilian
    Marquez, Karl
    Qiu, Jing
    Cho, Benjamin
    Tan, Yening
    Tong, Min
    Domingo, Christine
    Weiss, Leslie
    Argus, Elvira
    Sparks, Jessica
    Ostertag, Erica M.
    Coronella, Julia
    Sheldlock, Devon J.
    BLOOD, 2021, 138
  • [16] Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma
    Jinhuan Xu
    Qiuxiang Wang
    Hao Xu
    Chaojiang Gu
    Lijun Jiang
    Jue Wang
    Di Wang
    Bin Xu
    Xia Mao
    Jin Wang
    Zhiqiong Wang
    Yi Xiao
    Yicheng Zhang
    Chunrui Li
    Jianfeng Zhou
    Journal of Hematology & Oncology, 11
  • [17] Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma
    Yao, Xin
    Zhu, Shigui
    Huang, Jiaqi
    Qu, Xiaoyan
    Zhu, Judy
    Wei, Yutian
    Lan, Liping
    Lv, Xiaoteng
    Wu, Junfeng
    Wang, Rirfei
    Yang, Dingzhu
    Zheng, Chengxiao
    Zhao, DiJun
    Fan, Lei
    Huang, Fei
    Lu, Hua
    Zhang, Chaocan
    Chen, Cheng
    Li, Yanfeng
    Ren, Jiaqiang
    Zhang, Li
    Humphries, Michael
    Li, Jianyong
    Yao, Yihong
    BLOOD, 2019, 134
  • [18] Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma
    Xu, Jinhuan
    Wang, Qiuxiang
    Xu, Hao
    Gu, Chaojiang
    Jiang, Lijun
    Wang, Jue
    Wang, Di
    Xu, Bin
    Mao, Xia
    Wang, Jin
    Wang, Zhiqiong
    Xiao, Yi
    Zhang, Yicheng
    Li, Chunrui
    Zhou, Jianfeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [19] Therapy of Guillain-Barre syndrome
    Zagar, M
    Vranjes, D
    Bilic, E
    Mitrovic, Z
    Jurenic, D
    Sostarko, M
    Voglein, S
    NEUROLOGIA CROATICA, 2005, 54 (1-2): : 19 - 26
  • [20] Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy
    Deng, Jingjing
    Lin, Yuehui
    Zhao, Defeng
    Tong, Chunrong
    Chang, Alex H. H.
    Chen, Wenming
    Gao, Wen
    FRONTIERS IN ONCOLOGY, 2022, 12
12345